top of page

'There is Still Work to Be Done' -Dázon Diallo Talks with HIV.gov About Science of Treating HIV




SisterLove’s Dázon Dixon Diallo at CROI 2023 - HIV and Women


Key Takeaways

  • SisterLove, Inc Founder/President Dázon Dixon Diallo shared the impact of CROI on SisterLove's work and emphasized the need for access to science and tools to combat HIV.

  • The 13th International Workshop on HIV & Women discussed issues related to HIV and women, including updated breastfeeding/chestfeeding guidelines for people with HIV.

  • CROI serves as a forum for researchers to present and discuss important scientific discoveries in HIV and AIDS research, with over 3,400 researchers from 72 countries participating in the virtual and in-person conference.


Watch and share HIV.gov’s final interview from the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) with Dr. Dázon Dixon Diallo, Founder and President of SisterLove, about the impact of the scientific information presented at the conference on the HIV service community.



SisterLove. is the oldest women-centered HIV and sexual and reproductive justice advocacy organization in the southeastern United States.

In our conversation, Dr. Diallo discussed what she will share with SisterLove’s staff regarding the research findings at CROI that are relevant to the organization’s function. She emphasized that, based on what she heard at the conference, the organization’s community-driven work is on track.


Additionally, Dr. Diallo shared that the conference underscored that there is still work to be done to ensure that we have the science and tools needed “for women to get to the end of the [HIV] epidemic at the same time as everybody else.”



Dázon Dixon Diallo smiling in front of a microphone
Dázon hosts a weekly radio show and podcast

Intersectionality in Treating HIV

We also spoke with Dr. Diallo about a CROI pre-conference event, the 13th International Workshop on HIV & Women – From Adolescence to Menopause and Beyond. The workshop provided the opportunity for healthcare providers, researchers, and representatives from government, industry, and domestic and global communities to discuss issues related to HIV and women of diverse backgrounds. Dr. Diallo shared that the workshop has evolved to be more inclusive of all femme-identifying people, and the field has advanced, particularly in the area of pregnancy and people who could be pregnant.


She enthusiastically highlighted the workshop’s discussion about the recently released update to the HIV clinical guidelines for infant feeding. The update clarifies breastfeeding/chestfeeding guidance for people with HIV and supports shared decision-making between them and their healthcare providers.



Antoinette Jones of the Positive Women's Network stands to the left of Dázon Dixon Diallo of SisterLove, Inc an Atlanta nonprofit charity that offers free HIV testing
HIV-peer specialist A. Jones (l) and Dázon (r) for CNN

About this workshop, Dr. Diallo noted that “the equity issues came to the floor [regarding] how that plays out in different countries and different regions in the world.” She continued by noting the rarity of the workshop, in that it included women scientists, women with HIV, women advocates, and activists, and provided a forum for a conversation about science related specifically to people who identify as women. “That, to me, was golden!”


More about CROI

CROI provides a collaborative forum for clinical investigators and scientists to present, discuss, and offer critical feedback on their investigations regarding the epidemiology and biology of human retroviruses and related diseases.


The conference facilitates the presentation of important scientific discoveries and, thus, accelerates progress in the field of HIV and AIDS research. Seattle served as the host city for the 30th annual gathering, which took place from February 19 to 22 and included more than 3,400 HIV and infectious disease researchers from 72 countries who participated virtually and in-person.


Visit CROI’s website for additional information, including abstracts, session webcasts, and e-posters, and more on treating HIV, which are publicly available for 30 days after the conference’s conclusion.

 


Comments


bottom of page